A new antiprostatic agent for treatment of prostatic carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000813:Anilides / Q000627:therapeutic use*; D005485:Flutamide / Q000009:adverse effects / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
D000813:Anilides; D013739:Testosterone; D005485:Flutamide